NeoGenomics Inc (NEO)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -92,106 | -107,736 | -153,107 | -9,993 | -2,131 |
| Total assets | US$ in thousands | 1,638,040 | 1,681,230 | 1,740,030 | 1,869,780 | 988,331 |
| Operating ROA | -5.62% | -6.41% | -8.80% | -0.53% | -0.22% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $-92,106K ÷ $1,638,040K
= -5.62%
NeoGenomics Inc's operating return on assets (operating ROA) has shown a declining trend over the years, as evidenced by the figures provided. The operating ROA was -0.22% as of December 31, 2020, indicating that the company generated a very low return on its assets from its operations. Subsequently, the operating ROA decreased further to -0.53% by December 31, 2021, -8.80% by December 31, 2022, -6.41% by December 31, 2023, and -5.62% by December 31, 2024.
These negative operating ROA figures suggest that NeoGenomics Inc's operating income generated from its assets has been relatively low or even negative compared to the total assets employed in the business. A declining trend in operating ROA could indicate inefficiencies in the company's operations or challenges in generating profits from its asset base. It may be crucial for NeoGenomics Inc to closely evaluate and address the factors contributing to this decline to improve its operational efficiency and profitability in the future.